tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

CYBN Stock Latest News

Rising High: Numinus Wellness to sell five Utah clinics for $3.53M
The FlyRising High: Numinus Wellness to sell five Utah clinics for $3.53M
2h ago
ACB
CGC
Cybin’s CYB003 Shows Promising Results for Depression
PremiumCompany Announcements
Cybin’s CYB003 Shows Promising Results for Depression
3d ago
CYBN
Cybin: CYB003 data demonstres ‘breakthrough 12-month efficacy’ in MDD treatment
PremiumThe Fly
Cybin: CYB003 data demonstres ‘breakthrough 12-month efficacy’ in MDD treatment
3d ago
CYBN
Rising High: Cannabis firms report quarterly earnings
PremiumThe Fly
Rising High: Cannabis firms report quarterly earnings
7d ago
ACB
CGC
Cybin to Showcase Promising Depression Treatment Progress
PremiumCompany Announcements
Cybin to Showcase Promising Depression Treatment Progress
7d ago
CYBN
Cybin to Present Promising CYB003 Study Results
PremiumCompany AnnouncementsCybin to Present Promising CYB003 Study Results
7d ago
CYBN
Cybin price target lowered to $86 from $96 at Canaccord
Premium
The Fly
Cybin price target lowered to $86 from $96 at Canaccord
7d ago
CYBN
Cybin target adjusted to $25 at Alliance Global Partners following stock split
Premium
The Fly
Cybin target adjusted to $25 at Alliance Global Partners following stock split
7d ago
CYBN
Cybin’s Phase 3 Trials and Financial Update
PremiumCompany Announcements
Cybin’s Phase 3 Trials and Financial Update
8d ago
CYBN
CYBN Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
CYBN Upcoming Earnings Report: What to Expect?
12d ago
CYBN
Cybin to Highlight Innovations at Health Summit
PremiumCompany Announcements
Cybin to Highlight Innovations at Health Summit
21d ago
CYBN
Rising High: RIV Capital provides update on revenue, synergy realization
PremiumThe Fly
Rising High: RIV Capital provides update on revenue, synergy realization
28d ago
ACB
CGC
Cybin announces grant of patent in support of CYB005 phenethylamines program
PremiumThe FlyCybin announces grant of patent in support of CYB005 phenethylamines program
28d ago
CYBN
Three new option listings and one option delisting on October 23rd
Premium
The Fly
Three new option listings and one option delisting on October 23rd
29d ago
LB
CYBN
Cybin Inc. CEO to Speak at Research Event
Premium
Company Announcements
Cybin Inc. CEO to Speak at Research Event
2M ago
CYBN
Cybin Gears Up for Global Phase 3 Depression Trial
PremiumCompany Announcements
Cybin Gears Up for Global Phase 3 Depression Trial
2M ago
CYBN
Cybin Joins Prestigious Neuropsychiatry Summit
PremiumCompany Announcements
Cybin Joins Prestigious Neuropsychiatry Summit
2M ago
CYBN
Cybin price target lowered to $96 from $114 at Canaccord
PremiumThe Fly
Cybin price target lowered to $96 from $114 at Canaccord
2M ago
CYBN
Cybin Set to Launch Pivotal Phase 3 Depression Study
PremiumCompany Announcements
Cybin Set to Launch Pivotal Phase 3 Depression Study
2M ago
CYBN
Cybin Completes Share Consolidation; Maintains Ownership Ratios
PremiumCompany AnnouncementsCybin Completes Share Consolidation; Maintains Ownership Ratios
2M ago
CYBN
Cybin Inc. CEO to Speak at Global Investment Conference
Premium
Company Announcements
Cybin Inc. CEO to Speak at Global Investment Conference
3M ago
CYBN
Cybin Inc. Shareholders Approve Key Decisions
Premium
Company Announcements
Cybin Inc. Shareholders Approve Key Decisions
3M ago
CYBN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >